VentriPoint Diagnostics Ltd

Research VentriPoint Diagnostics Ltd (VPT) on Bullrun: market cap CAD 18.77M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CAD 18.77M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CAD 179.93K-CAD 3.20M-CAD 1.55Mn/an/aCAD 55.39KCAD 2.61M-CAD 4.12M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-29CAD 18.77Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 CAD.

About VentriPoint Diagnostics Ltd

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D and 3D ultrasound models.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is VentriPoint Diagnostics Ltd's market cap?

VentriPoint Diagnostics Ltd's market capitalization is CAD 18.77M.

What does VentriPoint Diagnostics Ltd do?

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D and 3D ultrasound models.